Gopal AK - Search Results

1

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy.

Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J, O'Meara MM, Fanale MA. Gopal AK, et al. Leuk Lymphoma. 2014 Oct;55(10):2328-34. doi: 10.3109/10428194.2013.876496. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24359243

2

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW. Gopal AK, et al. Bone Marrow Transplant. 2001 Mar;27(6):593-9. doi: 10.1038/sj.bmt.1702833. Bone Marrow Transplant. 2001. PMID: 11319588

3

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW. Gopal AK, et al. J Clin Oncol. 2007 Apr 10;25(11):1396-402. doi: 10.1200/JCO.2006.09.1215. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312330

4

The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.

Keeney GE, Gooley TA, Pham RN, Press OW, Pagel JM, Petersdorf SH, Maloney DG, Bensinger W, Holmberg L, Gopal AK. Keeney GE, et al. Among authors: gopal ak. Leuk Lymphoma. 2007 Oct;48(10):1961-7. doi: 10.1080/10428190701583983. Leuk Lymphoma. 2007. PMID: 17917964

5

Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.

Till BG, Gooley TA, Crawford N, Gopal AK, Maloney DG, Petersdorf SH, Pagel JM, Holmberg L, Bensinger W, Press OW. Till BG, et al. Among authors: gopal ak. Leuk Lymphoma. 2008 Jun;49(6):1062-73. doi: 10.1080/10428190801923725. Leuk Lymphoma. 2008. PMID: 18452065 Free PMC article.

6

Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-hodgkin and hodgkin lymphoma with severe hepatic dysfunction.

McCarthy J, Gopal AK. McCarthy J, et al. Among authors: gopal ak. Clin Lymphoma Myeloma. 2009 Apr;9(2):167-70. doi: 10.3816/CLM.2009.n.039. Clin Lymphoma Myeloma. 2009. PMID: 19406729

7

A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Forero-Torres A, Leonard JP, Younes A, Rosenblatt JD, Brice P, Bartlett NL, Bosly A, Pinter-Brown L, Kennedy D, Sievers EL, Gopal AK. Forero-Torres A, et al. Among authors: gopal ak. Br J Haematol. 2009 Jul;146(2):171-9. doi: 10.1111/j.1365-2141.2009.07740.x. Epub 2009 May 19. Br J Haematol. 2009. PMID: 19466965 Free article. Clinical Trial.

8

Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.

Gopal AK, Press OW, Shustov AR, Petersdorf SH, Gooley TA, Daniels JT, Garrison MA, Gjerset GF, Lonergan M, Murphy AE, Smith JC, Pagel JM. Gopal AK, et al. Leuk Lymphoma. 2010 Aug;51(8):1523-9. doi: 10.3109/10428194.2010.491137. Leuk Lymphoma. 2010. PMID: 20578815 Free PMC article. Clinical Trial.

9

Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.

Ram R, Gooley TA, Maloney DG, Press OW, Pagel JM, Petersdorf SH, Shustov AR, Flowers ME, O'Donnell P, Sandmaier BM, Storb RF, Gopal AK. Ram R, et al. Among authors: gopal ak. Biol Blood Marrow Transplant. 2011 Oct;17(10):1537-45. doi: 10.1016/j.bbmt.2011.03.010. Epub 2011 Apr 12. Biol Blood Marrow Transplant. 2011. PMID: 21536145 Free PMC article. Clinical Trial.

10

Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.

Budde LE, Guthrie KA, Till BG, Press OW, Chauncey TR, Pagel JM, Petersdorf SH, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Maloney DG, Gopal AK. Budde LE, et al. Among authors: gopal ak. J Clin Oncol. 2011 Aug 1;29(22):3023-9. doi: 10.1200/JCO.2010.33.7055. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters